vimarsana.com

Latest Breaking News On - செல்லுபடியாகும் கைபேசி - Page 5 : vimarsana.com

Easy Trip Planners IPO opens today at a price band of Rs186-Rs187 per equity share

This website uses information gathering tools such as cookies and other similar technologies. By clicking Accept on this banner or by using this website, you consent to the use of cookies unless you have disabled them. If you do not consent, do not use this website. It is at your, the user s, discretion to proceed with accessing this website. For more information, read the Cookie Policy under Online Privacy Policy. This website uses cookies.. This website uses information gathering tools such as cookies and other similar technologies. By clicking Accept on this banner or by using this website, you consent to the use of cookies unless you have disabled them. If you do not consent, do not use this website. It is at your, the user s, discretion to proceed with accessing this website. For more information, read the Cookie Policy under Online Privacy Policy.

Top stocks in focus: Reliance Industries, Axis Bank, Bharti Airtel, DLF, auto stocks

Reliance Strategic Business Ventures Limited (“RSBVL”), a wholly owned subsidiary of Reliance Industries Limited, announced that it has acquired additional equity stake in its investee company skyTran Inc. (“skyTran”) for a consideration of USD 26.76million. Axis Bank Limited (“the Bank”) has entered into a Memorandum of Understanding (MoU) amongst members of the consortium seeking to set up a Pan-India (National) Umbrella Entity (“NUE”) for Retail Payments. DLF plans to offer non-convertible debentures aggregating to Rs395cr. Airtel Digital Limited, wholly owned subsidiary of the Bharti Airtel has agreed to subscribe to 5,000 equity shares (10%) in Ferbine Private Limited. Auto stocks in focus as automakers will announce their February sales data.

Jaiprakash Associates receives approval to allot 1 18cr shares to Cowell and Lee Investment (Mauritius)

This website uses information gathering tools such as cookies and other similar technologies. By clicking Accept on this banner or by using this website, you consent to the use of cookies unless you have disabled them. If you do not consent, do not use this website. It is at your, the user s, discretion to proceed with accessing this website. For more information, read the Cookie Policy under Online Privacy Policy. This website uses cookies.. This website uses information gathering tools such as cookies and other similar technologies. By clicking Accept on this banner or by using this website, you consent to the use of cookies unless you have disabled them. If you do not consent, do not use this website. It is at your, the user s, discretion to proceed with accessing this website. For more information, read the Cookie Policy under Online Privacy Policy.

Top stocks in focus: Wipro, Torrent Pharma, NMDC, Jindal Stainless (Hisar), Tata Steel

Wipro appoints Michael Seiger as the Country Head for Germany and Austria. Torrent Pharma recorded a higher consolidated profit at Rs297cr in Q3FY21 against Rs251cr in Q3FY20; revenue increased to Rs1,995cr from Rs1,966cr yoy. NMDC registered sharply higher profit at Rs2,108cr in Q3FY21 against Rs1,375cr in Q3FY20, and revenue jumped to Rs4,355.1cr from Rs3,006.4cr yoy. Jindal Stainless (Hisar) Dec 2020 quarter: PAT and EBITDA of the company stood at Rs190cr and Consistent focus on deleveraging helped bring down the finance cost by 23% over CPLY. Tata Steel will announce its quarterly financial results on Tuesday.

Top stocks in focus: Maruti Suzuki, Britannia, PNB, Ashoka Builcon, AstraZeneca Pharma, BPCL

Maruti Suzuki’s production in January 2021 dropped to 1.60 lakh units from 1.79 lakh units in January 2020. Britannia reported a profit of Rs452.6cr in Q3FY21 against Rs368.9cr in Q3FY20. Revenue rose to Rs3,165.6cr from Rs2,982.7cr yoy. Punjab National Bank reported a profit of Rs506cr in Q3FY21 against Rs621cr in Q2FY21. Revenue fell to Rs8,313cr from Rs8,444.9cr qoq. Ashoka Buildcon reported a consolidated profit of Rs88.4cr in Q3FY21 against Rs32.4cr in Q3FY20, while revenue increased to Rs1,305.5cr from Rs1,280.4cr yoy. AstraZeneca Pharma India Limited has received Import and Market Permission in Form CT-20 from the Drugs Controller General of India for Dapagliflozin Tablets 10mg. The company will announce quarterly earnings today.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.